Monitoring medicines quality along the supply chain and detecting substandard, or falsified products are even more critical now, due to the impact of the COVID-19 pandemic on supply chains. Accordingly, the need to ensure standards are maintained for medicines used in the treatment of diseases including COVID-19 has been recognised by CARPHA. Market surveillance and […]